“Comparison of anti-thrombotic strategies using Bivalirudin, Heparin plus Eptifibatide, and Unfractionated Heparin Monotherapy for acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI): A single-center observational stu” (2021) University Heart Journal, 17(2), pp. 91–98. doi:10.3329/uhj.v17i2.54364.